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Abstract
For in vitro differentiation of bone marrow-derived mesenchymal stem cells/mesenchymal stromal cells into osteoblasts by
2-dimensional cell culture a variety of protocols have been used and evaluated in the past. Especially the external
phosphate source used to induce mineralization varies considerably both in respect to chemical composition and
concentration. In light of the recent findings that inorganic phosphate directs gene expression of genes crucial for bone
development, the need for a standardized phosphate source in in vitro differentiation becomes apparent. We show that
chemical composition (inorganic versus organic phosphate origin) and concentration of phosphate supplementation exert a
severe impact on the results of gene expression for the genes commonly used as markers for osteoblast formation as well as
on the composition of the mineral formed. Specifically, the intensity of gene expression does not necessarily correlate with a
high quality mineralized matrix. Our study demonstrates advantages of using inorganic phosphate instead of b-
glycerophosphate and propose colorimetric quantification methods for calcium and phosphate ions as cost- and time-
effective alternatives to X-ray diffraction and Fourier-transform infrared spectroscopy for determination of the calcium
phosphate ratio and concentration of mineral matrix formed under in vitro-conditions. We critically discuss the different
assays used to assess in vitro bone formation in respect to specificity and provide a detailed in vitro protocol that could help
to avoid contradictory results due to variances in experimental design.
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Introduction
Bone marrow-derived mesenchymal stem cells/mesenchymal
stromal cells (MSCs) have long been recognized as a powerful
source for the study of osteoblast behaviour and the regeneration
of bone tissue. In order to fully understand the mechanism of
differentiation and exploit the potential of MSCs for bone
regeneration it is indispensable to have a reliable and reproducible
in vitro model for osteogenic differentiation of MSCs to functional
osteoblasts.
In vitro systems for osteogenesis recapitulate events during direct
(desmal or intra-membranous) osteogenic differentiation. During
the in vitro differentiation into mature osteoblasts the down-
regulation of proliferation, secretion of an organic extracellular
matrix and mineralization of this matrix by deposition of
hydroxyapatite pose important developmental steps. These are
accompanied by a stage-specific expression of bone-related genes
[1]. In order to accomplish this process, culture media containing
varying concentrations of fetal bovine serum (FBS) are supple-
mented with additives. It is worth to note that many different
sources of FBS are used for the cultivation of MSCs, and that not
only the source, but even the batch of FBS can influence the cells,
resulting in an incalculable variability in experimental design [2,3].
Another disadvantage of FBS is its xenogenic origin when
considering in vivo applications in humans [4]. Dexamethasone, a
synthetic glucocorticoid which functions as glucocorticoid receptor
agonist, is used in most in vitro assays to induce osteogenic
differentiation through activation of Wnt/beta-catenin signaling
[5]. The effects of dexamethasone on cell proliferation, metabo-
lism and differentiation are concentration as well as context-
dependent [6–8]. For example, its effect on cell proliferation differs
between primary and secondary culture and it is thought that two
different osteoprogenitor cell populations exist, with only one
being dependent on dexamethasone for proliferation and osteo-
genic differentiation [9]. Ascorbic acid or a more stable derivative
like ascorbate-2-phosphate is added to the differentiation medium
to permit collagen type I fibril assembly. An external phosphate
source, generally inorganic phosphate or hydrolyzable substrates
like b-glycerophosphate (bGP), facilitates the mineralization of the
extracellular matrix (mainly collagen fibrils) produced by the cells
[10]. Most commonly 10 mM of bGP is added to a medium
(mainly DMEM or a-MEM are used, but also BGJb, DMEM:F12,
RPMI 1640 and others can be found in the literature [11]) already
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containing inorganic phosphate (Pi) and calcium ions (Ca
2+)
(1.0 mM inorganic phosphate and 1.8 mM calcium ions in the
case of DMEM as used in this study and a-MEM). In the literature
3 mM of sodium dihydrogen phosphate (NaH2PO4) or a mixture
of the sodium phosphate compounds disodium hydrogen phos-
phate (Na2HPO4) and NaH2PO4 buffered to a pH of 7.4 (from
here on referred to as NaxH3-xPO4), as well as 3 mM bGP and
other concentrations of these two phosphate sources have also
been used [5,10,12–17]. For a more in-depth review of
supplements and basal cell culture media for in vitro osteogenesis
we refer to Hoemann et al. and Boskey et al. [18,19]. In summary,
a considerable diversity has developed not only in respect to
protocols used for two-dimensional in vitro osteogenesis but also in
respect to the methods and methodology of analysis making it
difficult to transfer and compare results between different studies.
Routinely, the outcome of in vitro osteogenesis is being assessed
by the combination of gene expression analysis and either
histological staining for calcium and phosphate ions and/or the
measurement of tissue non-specific alkaline phosphatase (TNAP)
activity. However, more detailed analyses of the mineralized
matrix quality by X-ray diffraction (XRD) or Fourier-transform
infrared spectroscopy (FT-IR) are often missing.
Gene expression analysis is commonly used to investigate
osteogenic differentiation. Early events of osteogenic differentia-
tion include expression of collagen type I and TNAP [7]. IBSP, a
bone-specific glycoprotein that is involved in the nucleation of
hydroxyapatite [20], and osteopontin constitute the major part of
the non-collagenous extracellular matrix of bone. The latter is a
potent inhibitor of de novo hydroxyapatite formation and is thought
to be a negative regulator of mineralization and expressed at later
stages of osteogenic differentiation [21]. The function of osteocal-
cin (BGLAP), a protein that is expressed at late stages of osteoblast
differentiation, is still unclear, although there is some evidence that
osteocalcin, like osteopontin, is involved in the negative regulation
of bone formation [22].
The use of TNAP protein expression as an indication of
successful generation of functional osteoblasts alone is not very
suitable in several respects. Firstly, the histological staining using a
hydrolyzable substrate which yields a colored product is more a
proof of TNAP protein expression than of the actual degree of
TNAP activity under differentiation conditions. The osteogenic
induction medium, which contains potent inhibitors of its
enzymatic activity (Pi and pyrophosphate (PPi)) [21], is removed
prior to the staining. Although the measurement of TNAP
enzymatic activity is a more powerful method to visualize the
differentiation process than TNAP staining, it must be kept in
mind that TNAP is also expressed prominently in human
adipocytes and has an important function during the adipogenic
differentiation of MSCs [23]. Under classical in vitro osteogenic
conditions, a percentage of cells develops into adipocytes rather
than osteoblasts. Lastly, Hoemann et al. have noted that levels of
TNAP activity are not proportional to the mineralization process
[19].
The expression of the most common marker genes used for the
evaluation of in vitro osteogenesis can also be up-regulated by other
stimuli, and their expression is not limited to functional osteoblasts.
For example, osteocalcin was found to be expressed in neurons
[24], an adipocyte cell line and even human adipocytes [25,26],
blood platelets and megakaryocytes [27]. There is evidence that
osteocalcin plays an important role not only in the maturation of
bone, but also in the regulation of human metabolism [26]. This
highlights why it is advisable to base the assessment of in vitro
osteogenesis not only on mRNA and/or protein expression.
Apart from the analysis of genes and proteins involved in
osteogenesis and of the concomitant mineralization, the study of
the composition and quality of the mineralized tissue constitutes
the second major aspect of in vitro osteogenesis. The mineral in
bone matrix is made up mostly of carbonated hydroxyapatite,
which consists predominantly of calcium and phosphate ions in a
ratio of about 1.63 (in human bone) [28]. The most common
methods to visualize in vitro mineralization are the von Kossa and
the Alizarin Red S staining, with the former being used to detect
phosphate and the latter being used to test for calcium ions. A
major limitation of these methods is the lack of specificity in
respect to the ions detected [29,30]. Furthermore, the histological
staining cannot provide any information about the composition of
calcium phosphate precipitates formed: Not only hydroxyapatite,
but also all other calcium phosphate compounds lead to positive
staining results [29].
Although more sophisticated methods such as XRD, which is
considered to be the gold standard method for identifying mineral
phases [18], and FT-IR exist to assess the composition of the
extracellular matrix formed during in vitro osteogenesis, these are
not used often. Both XRD and FT-IR are quite technically
demanding and time-consuming methods usually not available in
the standard laboratory environment. Moreover, large quantities
of material are needed making their application difficult for cell
culture analysis. Thus, a simpler method to assess the mineral
composition of an in vitro sample is desirable.
In the present study we have examined the impact of different
phosphate sources and concentrations on gene expression as well
as on the temporal concentration of inorganic phosphate in the
media. Furthermore, we have evaluated the bone-like mineral
quality of these different samples via XRD and FT-IR analyses
and we have quantified the calcium and phosphate ion contents in
the cell layer by colorimetric methods. Calcium is measured by the
formation of a colored complex of calcium with o-cresolphthalein
complexone the absorption of which at 570/600 nm is propor-
tional to the amount of calcium present [31,32]. It needs to be
noted that the quantification of the calcium content in the cell
layer alone does not allow for reliable evaluation of a successful
mineralization, since for example apoptotic bodies as they are
present in dead cells may act as nucleating structures for calcium
crystal formation [33]. It is thus necessary to take the calcium to
phosphate ratio into account. Phosphate is assessed based on the
absorption of a complex formed between phosphate and malachite
green dye with molybdate the absorption of which at 620 nm is
proportional to the amount of phosphate. These cost- and time-
effective procedures to determine the calcium : phosphate ratio
and the amount of mineral matrix formed under in vitro conditions
were compared to XRD and FT-IR data.
In this study we demonstrate the distinct disadvantages of using
bGP as compared to inorganic Pi and show that the colorimetric
methods for the determination of calcium and phosphate ions are
valid alternatives to obtain an idea of the quality of the mineralized
matrix. Furthermore, a detailed protocol will be given for
osteogenic induction of human mesenchymal stem cells (see
Supplementary Information).
Materials and Methods
Materials
NaH2PO4, Na2HPO4, AgNO3, Alizarin Red S, tris(hydroxy-
methyl)aminomethane, ethanol and paraformaldehyde (PFA) were
purchased from Carl Roth GmbH, Karlsruhe, Germany. Sodium
L-ascorbate-2-phosphate, bGP-pentahydrate, dexamethasone, hy-
droxyapatite, and gelatin B (from bovine skin) were purchased
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from Sigma-Aldrich, Taufkirchen, Germany. Cell culture flasks
were from Greiner, Frickenhausen, Germany. Dulbecco’s Mod-
ified Eagle’s Medium with 1 g/l D-glucose (FG 0415) (DMEM),
phosphate-buffered saline (PBS) without Ca2+, without Mg2+, 106
trypsin-EDTA (0,5%/0,2% (w/v) in 106PBS, penicillin/strepto-
mycin (10000 U/ml/10000 mg/ml) and 1 M 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) were purchased from
Biochrom, Berlin, Germany. Cross-Linked C-telopeptides of Type
I Collagen (CICP) Elisa was purchased from Quidel, San Diego,
USA. TriReagent and Real Time PCR reagents were purchased
from Life Technologies, Darmstedt, Germany. Revert Aid First
Strand cDNA synthesis Kit and DNase I were purchased from
Fermentas, St. Leon-Rot, Germany. Human recombinant FGF-2
was purchased from Peprotech GmbH, Hamburg, Germany. Fetal
bovine serum (FBS) (Hyclone, South American origin, Lot
RWC35891) was purchased from Thermo Fisher Scientific,
Waltham, USA. In order to minimize effects of source and batch
of FBS, one single batch was used for all experiments. DIPI-500 -
QuantiChromTM Phosphate Assay Kit was purchased from
Gentaur, Brussels, Belgium. Calcium (CPC) LiquiColorH Test
was purchased from Stanbio, Boerne, USA.
Ethics Statement
Human tissues (bone marrow aspirates or a bone fragment,
respectively) were obtained after approval of the institutional
ethical committee of Medical School Hannover. Written informed
consent was obtained from all donors. All personal information
apart from age and gender was deleted. Bone marrow aspirates
were harvested by iliac crest aspiration during routine orthopedic
procedures from healthy donors and used for MSC isolation.
Small bone fragments were obtained from left-over tissue of one
additional donor during hip replacement surgery. These were used
for XRD studies.
Cell Culture
Human mesenchymal stem cells were prepared from human
bone marrow aspirates according to modifications of a protocol
described elsewhere [34]. Briefly, the aspirate containing
heparin was mixed with 3 volumes of PBS and filtered to
remove tissue debris. The resulting suspension was carefully
layered onto a density gradient of one volume Biocoll
(r= 1.077 g/ml) and centrifuged for 45 minutes at 10006g
without brakes. The mononuclear cells located at the interface
were harvested using a pasteur pipette, washed once in PBS,
resuspended in MSC medium and seeded in cell culture flasks
at a density of 1.6*105 cells per cm2 [11]. The MSC medium
consisted of DMEM supplemented with 10% (v/v) FBS (not
heat-inactivated), 20 mM HEPES, 1% (100 U/ml/100 mg/ml)
penicillin/streptomycin, and 2 ng/ml human recombinant FGF-
2 [35]. The cells were cultured at 37uC with 5% CO2 at 85%
humidity. They were washed in PBS and supplied with fresh
medium 24 hours after initial seeding, and subsequently every
3–4 days. The cells were always passaged at a density of around
70% by the use of 0.025% Trypsin-EDTA solution and seeded
at a density of 2*103 cells per cm2.
Osteogenic Differentiation
Mesenchymal stem cells from four different human donors were
used for the osteogenic differentiation tests. Donor A was a 53-year
old female, donor B a 47-year old male, donor C a 50-year old
female, and donor D was a 70-year old female. The cells from all
donors were used for the osteogenic differentiation tests in passage
five of in vitro culture. In order to induce osteogenic differentiation
the cells from the above described four different donors were
seeded in 6-well dishes and cell culture flasks (growth area: 75 cm2)
coated with 2% gelatin B at a cell density of 5*103 cells per cm2
and allowed to grow to confluence. Upon reaching confluence, the
MSC medium was replaced by osteogenic medium without FGF-2
and consisting of DMEM with 1 g/l D-glucose, 10% (v/v) FBS,
2% HEPES, 1% penicillin and streptomycin, 100 nM dexameth-
asone and 50 mM ascorbate-2-phosphate as well as one of the
following phosphate sources: 3 mM NaxH3-xPO4 (pH 7.4),
10 mM NaxH3-xPO4 (pH 7.4), 3 mM bGP, 10 mM bGP or no
external phosphate source. The medium for the control cells
consisted of DMEM with 1 g/l D-glucose, 10% (v/v) FBS, 2.5%
HEPES and 1% penicillin and streptomycin. The medium was
changed twice a week and prepared weekly. Cells for RNA
isolation were harvested on days 7, 14, 21 and 28. Quantification
of calcium and phosphate ions from the cell layer, FT-IR and
XRD analyses as well as Von Kossa and Alizarin Red S staining
were performed at day 28. For the quantification of the phosphate
concentration in the differentiation media, the supernatant from
all different media was harvested and stored at 220uC at each
change of medium. All experiments were performed independent-
ly with cells from the four different donors.
RNA Preparation and Analysis
During osteogenic differentiation, the cell layers from the 4
donors were harvested by incubation with TriReagent at room
temperature for 5 minutes and stored at –80uC at least overnight.
In addition, MSC samples from all donors (n = 19 including the 4
donors from the differentiation experiments) were collected at
passaging during expansion i.e. before reaching confluence. For
the study presented here, samples from passage 2 were analyzed
for their mRNA expression levels of collagen Ia1, osteocalcin and
TNAP. The frozen samples were thawed at room temperature,
100 ml of 1-bromo-3-chloropropane per ml of TriReagent were
added and centrifuged for 15 minutes at 20.0006g and 4uC. The
supernatant was carefully aspirated, mixed with 500 ml isopropyl
alcohol and centrifuged for another 30 minutes. After removal of
all fluid and a washing step with 80% ice-cold ethanol, the pellet
was dried and subsequently recovered in 20 ml of double distilled
water. The RNA concentration and purity was determined by
measuring the absorption at 260/280 nm. 1 mg of RNA was used
for cDNA synthesis, which was carried out after DNase treatment
to remove genomic DNA according to the protocol of the supplier
using random primers.
qRT-PCR
Real time PCR analysis was used to quantify the transcripts of
18S rRNA (Hs9999901_s1), bone sialoprotein (IBSP)
(Hs00173720_m1), osteocalcin (BGLAP) (Hs01587814_g1), osteo-
pontin (Spp1) (Hs00959010_m1) and tissue non-specific alkaline
phosphatase (TNAP) (Hs00758162_m1). The gene specific assays
and the Fast Advanced Mastermix were purchased from Life
Technologies.
Von Kossa Staining
Cells were washed with Tris-buffered saline (TBS), then fixed
in 4% (w/v) PFA in TBS for 30 minutes followed by another
three washes with TBS. A solution containing 5% (w/v) of silver
nitrate (AgNO3) was added to the cells and incubated in the
dark for 30 minutes. After this, the silver nitrate was removed
by three washes with double distilled water. The cells were then
stored in TBS in the dark until photographic documentation.
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Alizarin Red S Staining
Cells were washed with TBS, then fixed in 4% (w/v) PFA in
TBS for 30 minutes followed by another three washes with TBS.
1% (w/v) of Alizarin Red S (pH 9.5) was added to the cells for an
incubation period of 30 minutes. Subsequently, the cells were
washed several times with double distilled water until no further
discoloration of the water occurred. The cells were then stored in
TBS until photographic documentation.
XRD
To obtain sufficient material for the XRD investigations, cells
had to be cultured in 75 cm2 flasks. They were fixed in 4% (w/v)
PFA in TBS for 30 minutes followed by digestion with 1.5 ml
0.025% Trypsin-EDTA solution and incubation at 37uC for 48
hours. After centrifugation the supernatant was removed and the
remainder was dried in a vacuum concentrator for three days. For
sample preparation, the dried cell residue was fixed between two
transparent foils. The X-ray diffraction patterns were measured in
transmission using a Stoe StadiP diffractometer operated with
Ge(111)-monochromatized CuKa1 radiation with a wavelength of
l= 1.54060 A˚.
Human bone fragments were used for comparison. The samples
were stored at 220uC and pestled to a fine powder for XRD
measurements.
FT-IR
Cells were fixed in 4% (w/v) PFA in TBS for 30 minutes
followed by digestion with 0.025% trypsin-EDTA solution and
incubation at 37uC for 48 hours. After centrifugation the
supernatant was removed and the remainder was dried in a
vacuum concentrator for three days. For FT-IR analysis, the cell
residue was pestled with dry KBr to a homogeneous powder.
Transparent KBr pellets were pressed and were measured at a
Fourier-transforma infrared spectrometer (Tensor 27, BRUKER)
in transmission mode.
Quantification of Calcium and Phosphate Ions
Cells were fixed in 4% (w/v) PFA in TBS for 30 minutes,
washed twice in TBS, and harvested in 1 M HCl using a cell
scraper and incubated at 37uC for 48 hours. Cell debris was
removed by centrifugation and the supernatants were collected
and stored at 220uC for the subsequent quantification of calcium
and phosphate ions from the cell layer. The quantification of
calcium and phosphate ions in the cell layer was carried out using
the Calcium (CPC) LiquiColorH Test and the QuantiChromTM
Phosphate Assay respectively. Both tests were carried out
according to the protocols provided by the respective manufac-
turer. The medium supernatants harvested during the differenti-
ation process were also assayed for their phosphate concentration.
CICP
The MicroVue CICP assay was used to measure cross-linked
type I C-terminal collagen propeptide (CICP) in the differentiation
media in order to assess the collagen production of the cells during
osteogenic differentiation. It was carried out according to the
protocol provided by the manufacturer.
Data Analyses
The underlying IR bands of the FT-IR spectra were deduced by
curve-fitting assuming Gaussian bands (performed with PeakFit
4.12 by Seasolve), for which the peaks were derived from the
calculated second-derivative spectra (Origin Pro 9.0). The
reflections of the XRD pattern were resolved by curve-fitting
using Lorentzian fits (performed with PeakFit 4.12 by Seasolve),
for which the positions of the reflections were derived from the
calculated second-derivative spectra (Origin Pro 9.0). Statistical
analyses were performed using GraphPad Prism 5.0 (GraphPad
Software Inc.). Nonparametric Kruskal-Wallis test with multiple
comparison analysis with p#0.05 was used to detect significant
differences between groups, with p#0.05 significant = *,
0.01$p$0.001 very significant = **, p#0.0001 highly signifi-
cant = ***.
Results
bGP Causes Non-physiological Fluctuations in the
Availability of Free Phosphate
In order to induce osteoblast differentiation in mesenchymal
stem cells, the growth medium needs to contain a certain level of
free inorganic phosphate that allows for the mineralization to
occur. We have evaluated the concentration of free Pi in
osteogenic medium supplemented with different sources of
phosphate over the course of differentiation (Figure 1A and B:
Two representative donors are shown). With each change of
medium the concentration of free Pi declines dramatically when
the medium is supplemented with 10 mM b-glycerophosphate
(and to a lesser degree when the medium is supplied with 3 mM b-
glycerophosphate), whereas the Pi level remains fairly constant
when phosphate is supplemented as NaxH3-xPO4. The rate with
which b-glycerophosphate is hydrolyzed increases during the
course of osteogenic differentiation. Also, an inter-donor difference
in the rate of bGP hydrolysis is apparent (Figure 2, A: The same
two representative donors are shown). Figure 2 C and D (without
and with 14 days of pre-incubation of cells in osteo-inductive
medium respectively) depict the hydrolysis of bGP over time when
no changes of medium take place. Whereas during the first three
days of osteogenic induction there is no substantial difference in
the rate of bGP hydrolysis between donor A and a cell-free setting,
the cells of donor B exert a profound influence on the rate of bGP
hydrolysis (Figure 2 A, first versus third column). In order to assess
whether this inter-donor difference in the bGP hydrolysis rate
would dissipate during the course of osteogenic differentiation, the
cells were pre-incubated for 14 days in osteogenic medium
containing 10 mM bGP before repeating the above experiment
(Figure 2D). After these 14 days of pre-incubation the rate of bGP
hydrolysis in cells from donor A is comparable to the initial
hydrolysis rate of the cells from donor B (Figure 2A, second versus
fourth column), whereas the rate of bGP hydrolysis in cells from
donor B is even higher than without the pre-incubation period.
This means that in both cases bGP hydrolysis notably increases
through prestimulation of the cells in osteogenic medium
(Figure 2A: columns 2 and 4 compared to columns 1 and 3,
respectively). This difference in phosphatase activity is reflected by
the TNAP mRNA expression levels of donor B in comparison to
donor A (Figure 2 B). Similar albeit less significant results were
obtained for 3 mM bGP supplementation (data not shown). A
possible explanation for the notable difference in Pi hydrolysis
between donor A and B might be due to a huge difference in
TNAP mRNA expression (more than 20 fold higher in donor B as
compared to donor A, see Figure S1). We did not find a
relationship between TNAP expression and donor age. The
supplementation with 50 mM ascorbate-2-phosphate exerts no
significant influence on the rate and level of phosphate release
(data not shown).
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Phosphate Source and Concentration Influence Gene
Expression of Commonly Used Osteogenic Marker Genes
It has been shown by Beck et al. that Pi is involved in the
regulation of osteogenesis-related genes such as osteocalcin and
osteopontin and that the influence of Pi on gene expression is
concentration dependent [36–38]. We were able to confirm this
result for osteocalcin for increasing concentrations of Pi. Interest-
ingly, we found that the use of 10 mM NaxH3-xPO4 seemed to
have the opposite effect (Figure 3 A and B). On the contrary,
TNAP and IBSP mRNA levels decrease with increasing Pi
concentrations when cells are cultured in osteogenic induction
medium (Figure 3 C and D). There are no substantial differences
in gene expression between control and osteo-induced cells at days
7 and 14 for osteocalcin and osteopontin (data not shown).
In addition, we assessed the basal mRNA expression levels of
osteocalcin, collagen Ia1 and TNAP among the cells from all 19
donors (including the 4 donors from the main study) during
expansion of the MSC cultures at passage 2. There was a high
inter-donor variability. There was a high inter-donor variability
and therefore no significant differences were observed in the gene
expression levels (Figure S1).
FT-IR Results Demonstrate an Increase in the Mineral to
Matrix Ratio with Increasing Levels of Free Phosphate
and an Increase in Mineral Maturity for Low
Concentrations of Free Phosphate
The FT-IR spectra of those samples which were supplemented
with phosphate during osteogenic differentiation are all very
similar both to the reference FT-IR spectrum of human bone and
to spectra found in the literature (Figure 4). The spectra of the
control and of the sample with 1 mM Pi show very weak bands
characteristic for organic matrix components (amide I mode near
1650 cm21 and amide II mode near 1550 cm21 [39]) but no
bands that hint at the deposition of calcium phosphate (b1,b3
phosphate region (900–1180 cm21) [40]) and will thus not be
considered further.
Apart from minor variances there are no qualitative differences
between the IR spectra of the samples supplemented with 3 mM
NaxH3-xPO4, 10 mM NaxH3-xPO4, 3 mM bGP, and 10 mM
bGP. However, some aspects are worth noting: The mineral to
matrix ratio (integrated peak area of phosphate bands divided by
the integrated peak area of the amide I band) increases with rising
levels of free phosphate (Table 1) [39]. Furthermore, the maturity
indicated by the type of collagen crosslinks (determined by the area
ratio of the pyridinoline (1660 cm21) and the dehydrodihydrox-
ylysinonorleucine (1690 cm21) FT-IR bands) also increases from
3 mM bGP via 3 mM NaxH3-xPO4 to 10 mM bGP (Table 1).
This ratio can be correlated to the ratio of nonreducible/reducible
collagen cross-links in bone, which increases with bone maturation
[41].
In contrast, the mineral maturity (corresponding to the ratio of
well-crystallized stoichiometric hydroxyapatite to nanocrystalline
apatites, measured by the ratio of the 1030 cm21 and the
1110 cm21 IR bands (found in nanocrystalline apatites [42]) is
highest for 3 mM bGP and 3 mM NaxH3-xPO4. The additives
10 mM NaxH3-xPO4 and 10 mM bGP lead to the formation of a
higher percentage of nanocrystalline apatites (Table 1).
The characteristic peaks of hydroxyapatite are present in the
spectra of all samples that were supplemented with additional
phosphate. Apart from the bands attributable to hydroxyapatite
(472, 561, 575, 601, 962, 1040, and 1092 cm21) there are several
bands present that hint at the presence of other calcium
phosphates, such as dicalcium phosphate (892, 992, 1128, 1175,
1650 cm21), dicalcium phosphate dihydrate (1070, 1132, 1646,
1730, and 2850 cm21), and b-tricalcium phosphate (945, 972,
1041, 1094, and 1119 cm21) [43]. The carbonate peak at
872 cm21 is also represented in all spectra.
Figure 1. Free phosphate concentration. Concentration of free phosphate in the medium over the course of differentiation depending on the
different phosphate sources shown for donors A and B respectively. Plotted as mean6 SD (small SD are not visible). A. Donor A (53-year old female).
B. Donor B (47-year old male). Donors were chosen for relatively high difference in TNAP mRNA expression.
doi:10.1371/journal.pone.0065943.g001
Standards in In Vitro Osteogenic Differentiation
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e65943
XRD Results Demonstrate Formation of a
Hydroxyapatite-like Matrix Independent of Phosphate
Source and Concentration
Figure 5 shows representative XRD diffraction patterns of
samples supplied with different sources of phosphate for differen-
tiation. The underlying diffractions were curve-fitted. All phos-
phate supplements led to the formation of a mineralized matrix.
The identified signals in the XRD patterns correspond to the
reflections of hydroxyapatite and the diffraction patterns resemble
that of human bone. The increased width of the signals may be
due to a reduced crystallinity of the mineral formed or may
indicate the formation of very small nanoparticles. No signals
characteristic of monetite or octacalcium phosphate are found in
any of the spectra. The XRD patterns of samples obtained with
Figure 2. bGP hydrolysis and TNAP mRNA expression. A. Differences in phosphate hydrolysis over 3 days depending on the donor cells with
(*) or without 14 days of pre-incubation in osteo-inductive medium containing 10 mM bGP with normal changes of medium. The free Pi
concentration generated under cell-free conditions has been subtracted. Plotted is mean 6 SD. B. Real-time PCR mRNA expression data of TNAP for
donor B relative to donor A on days 7, 14, 21 and 28 of the osteogenic differentiation. C. Stability of bGP in the medium with cells and under cell-free
conditions (no changes of medium) without pre-incubation of cells. Data plotted as mean 6 SD (small SD not visible) D. Stability of bGP in the
medium with cells and under cell-free conditions (no changes of medium) with 14 days of pre-incubation in osteo-inductive medium containing
10 mM bGP with normal changes of medium.
doi:10.1371/journal.pone.0065943.g002
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10 mM bGP and 10 mM NaxH3-xPO4 show a weak broad signal
between 30 and 32u 2H which hints at the presence of small
amounts of amorphous calcium phosphate that may have formed
by spontaneous precipitation due to the high concentration of
phosphate ions.
At Low Concentrations of Free Phosphate the Calcium to
Phosphate Ratio is Similar to Bone
The calcium to phosphate ratios of the mineralized matrix as
determined by the measurement of calcium and phosphate ion
content of the cell layer for the samples obtained from cell cultures
with different phosphate additives are shown in Figure 6 A.
Samples prepared in the presence of 3 mM bGP and 3 mM
NaxH3-xPO4 both show ratios that are close to the ratio observed
in human bone (1.63). The ratio decreases with higher phosphate
concentrations and is lowest for 10 mM NaxH3-xPO4 with a ratio
around 1. There is an inverse relationship between the calcium to
phosphate ratio and the mineral to matrix ratio that has been
calculated from the FT-IR spectra. The amount of mineral formed
increases with rising levels of free inorganic phosphate (Figure 6 B).
Von Kossa- and Alizarin Red S Staining Confirm
Mineralization of the Cell Layer
The von Kossa staining as an indicator of phosphates and the
Alizarin Red S staining as an indicator of calcium ions in the cell
layer were positive for all samples cultured in osteogenic induction
medium except for the one not containing an additional source of
inorganic phosphate (Figure S2).
High Concentrations of Free Phosphate Diminish CICP
Production
It is thought that mineralization can occur in association with
collagen fibrils of the extracellular matrix or in connection with
cell debris derived from apoptotic cells [44]. The synthesis of
collagen is hence an important parameter of osteogenic differen-
tiation and was measured in our experiments by enzyme-linked
immunosorbent assay for the detection of the collagen Type I C-
terminal collagen propeptides, which are cleaved from collagens during
the maturation process. The release of the propeptides is
proportional to the production rate of collagens.
The addition of 3 mM bGP, 3 mM NaxH3-xPO4 or 10 mM
bGP to the osteogenic induction medium leads to an enhanced
collagen synthesis (Figure 7). Conversely, the addition of 10 mM
Figure 3. mRNA expression levels of osteogenic marker genes. mRNA expression levels of osteocalcin, osteopontin, TNAP and IBSP after 28
days of osteogenic differentiation depending on the phosphate source. The relative mRNA expression (D Ct) is plotted against the phosphate
supplementation for five different genes involved in the formation of bone (n = 4). Plotted as mean 6 SD.
doi:10.1371/journal.pone.0065943.g003
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NaxH3-xPO4 severely reduces the formation of new collagen.
Dexamethasone and ascorbate-2-phosphate apparently exert no
influence on the collagen production as the level of CICP in the
sample containing no Pi supplementation is similar to the level in
the control sample (Figure 7).
Discussion
Originally, the rationale for using bGP as a source for
phosphate ions was that ‘‘phosphate ions should be made available
in places where alkaline phosphatase was present, thereby
reducing the possibility of nonspecific mineral precipitation’’
[45]. This rationale would however only benefit the mineralization
process if the hydrolysis of bGP was limited exclusively to the
phosphatase activity of the cells. As bGP becomes hydrolyzed
under cell-free conditions (Figure 2C, D, see cell-free conditions),
there is no benefit in using bGP rather than NaxH3-xPO4. In light
of the donor variability in bGP metabolism of human MSCs that is
presented in this study it seems advisable to avoid the use of
indirect phosphate sources if comparable conditions for in vitro
osteogenesis are necessary for the experimental setup. We have
screened MSCs from 19 different donors for their TNAP mRNA
expression levels (Figure S1). Up to 53-fold differences in mRNA
expression levels were found. The high inter-donor variability in
TNAP expression levels and the resulting differences in the rate of
phosphate release from bGP might account for the high inter-
donor variability in osteocalcin and osteopontin gene expression.
Furthermore the extreme fluctuations in free phosphate caused by
the use of bGP are non-physiological and may exert an
uncalculable influence on the differentiation process since it
introduces a variable parameter dependent on the rate of Pi
hydrolysis of the cells used. This is in line with the results of
Figure 4. FT-IR spectra. FT-IR spectra (450–1750 cm21) of samples cultured in different osteogenic induction or control media (n = 1) show the
characteristic hydroxyapatite bands and the bands characteristic of the organic matrix of bone.
doi:10.1371/journal.pone.0065943.g004
Table 1. Matrix and mineral characteristics derived from FT-IR data.
phosphate additive
Collagen crosslink
(1690/1660 cm21 ratio)
mineral maturity
(1030/1110 cm21 ratio)
mineral to matrix ratio
(phosphate/amide I ratio)
3 mM bGP 1.75 3.27 5.99
3 mM NaxH3-xPO4 1.95 3.26 6.42
10 mM bGP 2.29 3.19 7.31
10 mM NaxH3-xPO4 2.03 2.91 9.21
Representative data of one donor for collagen crosslinks, mineral maturity and mineral to matrix ratios dependent on different phosphate additives in the osteo-
induction medium.
doi:10.1371/journal.pone.0065943.t001
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Khoshniat et al., who showed that the gene expression of both
osteocalcin and osteopontin changes in response to an external
phosphate stimulus as soon as 30 minutes after the addition of
phosphate to the culture medium [46]. They also reported the up-
regulation of osteocalcin and osteopontin in a Pi concentration-
dependent manner [46,47]. While our data does show a Pi
concentration dependent up-regulation of osteocalcin and osteo-
pontin, this holds true only within a certain concentration range.
At 11 mM of free Pi (1 mM basal concentration in the medium
and 10 mM added as NaxH3-xPO4) these two genes become
down- rather than up-regulated. Therefore, a critical maximum
free Pi concentration seems to exist, above which the gene
expression of osteocalcin and osteopontin becomes repressed
rather than activated.
The FT-IR data also show that mineral maturity suffers from
more highly concentrated phosphate supplements. Apart from
that, it can be concluded that with all phosphate supplements
tested, the spectra are similar to the spectrum of a bone reference.
The spectra from the different phosphate supplementations clearly
demonstrate that the mineral formed is hydroxyapatite, as
becomes apparent upon comparison with the FT-IR hydroxyap-
atite reference spectrum. Like the FT-IR spectra, the XRD
patterns for all different phosphate supplementation groups are
similar to each other as well as to the bone reference. The
prominent reflections of hydroxyapatite are present in all patterns,
and diffraction patterns typical of other calcium phosphate
compounds such as octacalcium phosphate are absent. When
comparing the diffraction patterns obtained from the groups with
the higher phosphate concentrations 10 mM bGP and 10 mM
NaxH3-xPO4 to those obtained with 3 mM bGP and 3 mM
NaxH3-xPO4 the subtle broad peak characteristic of either partially
amorphous material or of the formation of very small calcium
phosphate nanoparticles becomes apparent, which shows that with
10 mM bGP and 10 mM NaxH3-xPO4, a certain degree of
spontaneous precipitation takes place. This spontaneous precipi-
tation of calcium phosphate also explains the decrease of the
calcium to phosphate ratio of the mineralized matrix (Figure 6 A)
with higher phosphate concentrations. The cause for the
precipitation lies in the super-saturation of the differentiation
media (Table 2). At a pH of 7.4, amorphous or only partially
crystalline calcium phosphates precipitate when the solubility
product of 5.5 mM2 is exceeded [18]. As proteoglycans have an
inhibitory effect on this precipitation, the concentration product of
Ca2+ and Pi can actually lie above this value [48], which accounts
for the absence of amorphous calcium phosphate at the lower
phosphate concentrations.
As already mentioned in the introduction, the von Kossa or the
Alizarin Red S staining methods are used to assess the mineraliza-
tion of the samples treated to osteogenic induction. The former
makes use of the fact that silver phosphate has a low solubility
product: silver nitrate is added to the cell layer leading to yellow
deposits of silver phosphate being formed when calcium
phosphates are present. However, Ag+ ions can also react with
carbonate ions to silver carbonate which precipitates as a white
solid and, like silver phosphate in the presence of organic material,
turns to black upon exposure to light. This makes it impossible to
discriminate between phosphates and carbonates and can lead to a
false positive staining pattern, thus making the von Kossa stain useful
only when both staining and documentation procedures are
performed in the absence of light. During Alizarin Red S staining
the dye forms red chelate complexes with divalent cations, here
Ca2+. Alizarin Red S is commonly used at an acidic pH around 4.5.
Puchtler et al. have pointed out that the staining at a low pH will
lead to diffusion artifacts. Furthermore, they have shown that
Alizarin Red S will also form red chelates with cations of many other
compounds [29]. Calcium-binding proteins and proteoglycans are
also detected by this staining [49]. Therefore, this staining
procedure should be performed at a pH of 9.5 and likewise be
interpreted with care. In summary, histochemical staining is a
limited substitute for physicochemical assays on the nature of the
mineral formed [18]. The limitations to both the von Kossa and the
Alizarin Red S staining methods call for a method that can prove the
concomitant presence of calcium and phosphate ions in the cell
layer and thus hint at a mineralized extracellular matrix typical for
bone.
In the experiments performed by our group we found the
quantification of calcium and phosphate ions extracted from the
cell layer to be a fast and inexpensive alternative for the
histological staining. The presence of precipitated calcium
phosphate in the mineral formed was detected in our experiments
by this method via the calcium to phosphate ratio. It must be
noted however, that this method does not allow for the
discrimination between ions from deposited calcium phosphate
and ions that were bound to proteins.
When comparing the usefulness of XRD and FT-IR analyses to
the ion quantification, it needs to be made clear that the calcium to
phosphate ratio does not give direct information on the calcium
phosphate compounds formed in the extracellular matrix during
the differentiation process, but in the experiments performed here
it correlates well with the information derived from the XRD
patterns: ratios close to the ratio found in bone correlate with
Figure 5. XRD patterns. XRD patterns of cells after osteogenic
differentiation for 28 days supplemented with different sources of
phosphate. Additionally, a fragment of human hip bone has been used
as a reference sample of human bone. With second-derivation curve
fitting analysis discrete reflections at 25.9 (002), 31.77 (211), 32.18 (112),
32.9 (300), 34.04 (202), and 39.79u (310) were detected for all samples
supplemented with phosphate as well as for the bone reference
sample. These reflections correspond to prominent peaks of hydroxy-
apatite [50].
doi:10.1371/journal.pone.0065943.g005
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XRD patterns similar to XRD patterns found in bone and of
hydroxyapatite. The spontaneously formed calcium phosphate
precipitates received at higher phosphate levels could not be
detected in the FT-IR spectra and only produced a weak broad
peak in the XRD pattern, whereas they were clearly represented
by a calcium to phosphate ratio lower than that found in human
bone.
Conclusions
Gene expression analysis alone is not a sufficient tool to assess
in vitro osteogenic differentiation as the common marker genes
osteocalcin and osteopontin are up-regulated by the addition of
phosphate to the differentiation medium and thus do not represent
reliable markers for the differentiation process itself, although their
expression levels seem to increase with the amount of mineral
deposited increasing (not true for 10 mM NaxH3-xPO4 as
discussed above). The up-regulation of both TNAP and IBSP is
not linked dose-dependently to the phosphate level present in the
medium, and their expression does not correlate with the
mineralization process.
When XRD analysis is not an option (due to inavailability or the
rather large sample amounts needed), the quantification of the
calcium and phosphate content of the cell layer should replace the
classic histological von Kossa and Alizarin Red S staining as the
histological methods for reasons given above. The quantification
should be performed together with gene expression analysis of
IBSP, TNAP, osteocalcin, and osteopontin.
The use of high phosphate concentrations to enhance the in vitro
osteogenic differentiation should be avoided for several reasons.
Firstly, high concentrations of free phosphate can have a
deleterious effect on gene expression. Secondly, the use of
10 mM bGP leads to extreme non-physiological fluctuations of
the extracellular phosphate level. As it is well known that the
extracellular phosphate concentration directly influences tran-
scription of several genes crucial for osteoblast development, such
a fluctuation should be avoided. Lastly, we have shown that high
concentrations of free phosphate in the differentiation medium
lead to a lowered calcium to phosphate ratio in the cell layer,
which is probably due to spontaneous precipitation of calcium
phosphate.
In light of the results obtained by gene expression, XRD and
FT-IR analysis as well as by calcium and phosphate ion
Figure 6. Calcium to phosphate ratios and ion concentration in the cell layer. A. Calcium to phosphate ratio. Calcium and phosphate ions
were extracted from the cell layer of four different donors and quantified. Data are mean6 SD for n = 4 donors. B. Calcium and phosphate content of
the cell layer after 28 days of osteogenic induction with different phosphate additives. Data are mean 6 SD for n= 4 donors.
doi:10.1371/journal.pone.0065943.g006
Figure 7. Rate of collagen synthesis. CICP assay of the supernatant
during osteogenic induction. Data are mean of days 14 and 216 SD for
n = 4 donors.
doi:10.1371/journal.pone.0065943.g007
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concentration quantification, it seems advisable to use lower
concentrations of phosphate, such as 3 mM NaxH3-xPO4 (resulting
in a total Pi concentration of 4 mM) when working with human
mesenchymal stem cells, as these supplements led to a mineralized
matrix of good quality for all donor cells tested. NaxH3-xPO4 is
superior to bGP in respect to providing an invariable source of free
phosphate. The only disadvantage lies in the fact that a lot of data
on in vitro osteogenic differentiation of human mesenchymal stem
cells has been generated with 10 mM bGP as phosphate source,
thus making it difficult to compare data to those studies.
Nevertheless, we think it worth to consider a switch.
A detailed protocol for the in vitro osteogenic differentiation of
human mesenchymal stem cells is given in the Supporting
Information.
Supporting Information
Figure S1 mRNA expression of osteogenic marker genes.
Relative mRNA expression of osteocalcin, collagen Ia1 and
TNAP from 19 different donors in passage two of in vitro culture.
The four donors used in this project for the osteogenic
differentiation tests are marked accordingly. Cells were harvested
before reaching confluence.
(TIF)
Figure S2 Von Kossa and Alizarin Red S staining. Represen-
tative data from day 28 of the osteogenic differentiation for the
different phosphate sources is shown (Alizarin Red S: left panel,
von Kossa: right panel)
(TIF)
Protocol S1.
(DOCX)
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